#hemodialysis cost per session

[nefronkidneycare]

An arteriovenous fistula (AV fistula) is a vascular access used for hemodialysis treatments in people with end stage renal disease (ESRD). It is the preferred vascular access type for hemodialysis because it is associated with fewer complications and better long-term outcomes than other types. Contact us now.

[thedataproject]

Find a Dialysis Center Near You: Comprehensive Guide

Chronic kidney disease (CKD) is said to affect almost 37 million Americans, while approximately 786,000 are already at the point of end-stage renal disease - a condition wherein the kidneys have completely lost their ability to do their job efficiently, and when dialysis or a kidney transplant is essentially needed to sustain life. In replacing some functions of the kidneys, dialysis filters out waste and excess fluids from the blood when the kidneys can no longer do this. Because treatments can be several hours, repeated several times a week, the selection of a dialysis center is an important part of the management of the disease.

In this informative guide, we are going to take a closer look at the types of dialysis, how to choose a center, and provide practical steps in finding the best dialysis facility near you with resources from Find Dialysis Centers directory. We'll also provide crucial statistics, facts, and references so you can make an educated decision.

1. Understanding Dialysis: What Are Your Options?

Dialysis is a treatment for patients whose kidneys have lost most or all of their functional abilities. The two major forms of dialysis - hemodialysis (HD) and peritoneal dialysis (PD) - are suited for different types of patient needs.

Hemodialysis (HD)

How It Works: Hemodialysis cleans the waste and excess fluid from your blood with the aid of a machine known as a hemodialyzer. During treatment, blood will leave your body and then pass through this filtering machine, after which it will be returned to the body. One session of hemodialysis typically lasts from 3 to 5 hours and is done three times a week.

Patient Experience: HD can be performed either in a dialysis center, in a hospital, or at home-with proper training. In-center hemodialysis remains the most common modality, with supervision by trained healthcare professionals during treatment.

Who It’s For: Hemodialysis is best suited for individuals who need regular treatment professionally supervised or prefer structured schedules. As of 2016, the U.S. Renal Data System (USRDS) reported that 89% of dialysis patients in the United States use hemodialysis.

Peritoneal Dialysis (PD)

How It Works: In peritoneal dialysis, a catheter is inserted into the abdominal cavity, a sterile cleansing fluid called dialysate is infused into the abdomen. The peritoneum, which lines the abdomen, acts as a filter; after absorbing waste products, the fluid is drained. It can be done at home-typically several times a day-or by using a machine overnight.

Patient Experience: PD tends to be more flexible than many other treatment modalities, as patients can conduct treatments in the comfort of their own home or even while at work. That makes it a good fit for patients placing a premium on autonomy.

Who It’s For: PD is a popular alternative for patients who would wish to have more control over their treatment schedule. It is an operation with less invasion compared to hemodialysis and has no needles in many cases. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), about 11% of dialysis patients go for peritoneal dialysis.

Key Statistics:

Average life expectancy on dialysis: 5-10 years, although some patients live 20 or more years with appropriate care.

Average dialysis cost: Hemodialysis costs approximately $89,000 per year while peritoneal dialysis costs about $71,000 annually.

2. How to Find a Dialysis Center Near You

Finding a dialysis center that best fits your medical needs, personal preferences, and lifestyle is essential in maintaining health. How to make this search effective:

Step 1: Use an Online Dialysis Center Directory

Some directories, such as Find Dialysis Centers, will allow a search based on location, services, and star ratings for dialysis centers. With over 7,600 listings of United States dialysis centers in their directory, this directory makes a comparison of dialysis centers in your area based on your zip code or city.

Why Location Matters: For most dialysis patients receiving three treatments a week, location is key. Ease of travel can make the difference between sticking to a schedule and either missing sessions or experiencing treatment fatigue. A number of studies have shown that patients residing closer to their dialysis centers have higher adherence with fewer complications.

Step 2: Check Medicare Star Ratings

For instance, dialysis centers in the United States maintain a star rating from 1 to 5 in various areas of concern, including infection rates, hospitalizations, and patient survival rates.

Why It Matters: Facilities with more stars have been associated with better outcomes, fewer hospitalizations, and better long-term survival. A superior quality of care is concentrated within facilities with 4 or 5 stars.

Step 3: Filter by Services Offered

Other than the generic in-center hemodialysis, the services provided by dialysis centers may include a multitude of different offerings, including:

Home dialysis training: Many of the facilities provide training for patients who are anxious to take care of home hemodialysis (HHD) or peritoneal dialysis themselves.

Nocturnal dialysis: For working patients, several centers may provide overnight dialysis treatment sessions, allowing a patient to dialyze while sleeping.

Vascular access care: Fistulas or catheters are often required to continue hemodialysis, and some centers have specialized care for this.

3. Key Factors in Evaluating Dialysis Centers

Choosing a dialysis center isn't just about location. The care is indicative of the quality, and the skill of those performing it, and so are the patient outcomes.

Staff-to-Patient Ratios

Centers with a lower ratio of staff to patients allow for more individualized care, which may improve patient outcomes. A center that has fewer patients assigned per staff member can monitor each patient more closely, which minimizes the chances of complications such as infection or low blood pressure during dialysis.

Infection Control

Infection is perhaps the most serious risk with dialysis, but especially with patients on hemodialysis through catheters or fistulas. Estimates by the Centers for Disease Control and Prevention (CDC) approximate that the death toll by bloodstream infections kills over 34,000 dialysis patients each year. Look for facilities that have low rates of infection and those that follow strict hygiene practices.

Patient Outcomes and Mortality Rates

Check the center's mortality rates and hospitalization rates compared to national averages. Generally, the higher quality the center is, the better the outcomes and most report these statistics on their websites.

Fact: Studies have shown that patients dialyzing in facilities with more nurses on staff have a 20 percent lower mortality rate compared to patients that are treated in understaffed centers.

4. Financial Considerations: Understanding Insurance and Costs

Dialysis is an expensive treatment, but for patients with end-stage renal disease (ESRD). Medicare pays 80% of dialysis costs regardless of age. The remaining costs are usually paid by Medicaid or private insurance.

Navigating Insurance Coverage

Medicare ESRD Program: Covers all ESRD patients in the United States and covers, after a three-month waiting period, the cost of hemodialysis and peritoneal dialysis. Once coverage kicks in, Medicare will cover 80% of treatment costs.

Out-of-Pocket Costs: Still, copays, deductibles, or the cost of medications are paid by the patients. At most centers there are financial counselors who will provide assistance to patients to review their insurance coverage and apply for additional financial assistance programs available such as the American Kidney Fund.

5. Specialized Care and Support Services

In addition to dialysis treatment, patients have many support services that facilitate quality of life and help achieve successful long-term outcomes.

Nutritional Counseling

The patients requiring dialysis must adhere to strict dietary styles that limit their fluid and food intake containing potassium, phosphorus, and sodium. A registered dietitian at the dialysis center will be in the position to offer specific nutrition counseling aimed at averting complications such as hyperkalemia (high potassium).

Mental Health and Emotional Support

It is burdensome to live with kidney failure; sometimes the physical and emotional stress is overwhelming for the patients, which may be helped by the availability of mental health counseling and social workers at dialysis centers to fight against depression, anxiety, and emotional burden of chronic illness.

Vascular Access Management

For a hemodialysis patient, a good vascular access site be it fistula, graft, or catheter is equal to life. Vascular access facilities stand by the patient in the prevention of complications of infection, clotting, or poor blood flow that might disrupt treatment.

Conclusion: Making the Right Choice for Your Health

It is life-supportive treatment, and success means finding a compatible dialysis center. Pay attention to location, expertise of staff members, patient outcomes, and additional support services to make a well-rounded decision that best fits your needs-medically and personally. Make use of various resources, like the Find Dialysis Centers directory, to compare centers based on location, ratings, and services provided.

While dialysis can be long-term, the right center will make treatment much easier and vastly improve your quality of life.

References:

National Kidney Foundation. Chronic Kidney Disease in the United States. https://www.kidney.org/kidney-topics/chronic-kidney-disease-ckd

U.S. Renal Data System. Annual Data Report: Epidemiology of Kidney Disease in the United States https://usrds-adr.niddk.nih.gov/2023

Centers for Disease Control and Prevention (CDC). Hemodialysis-associated Infections. https://www.cdc.gov/dialysis-safety/about/index.html

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Treatment Methods for Kidney Failure: Peritoneal Dialysis. https://www.niddk.nih.gov/health-information/kidney-disease/kidney-failure/choosing-treatment

American Kidney Fund. Financial Assistance for Dialysis Patients - https://www.kidneyfund.org/get-assistance

[omkarpatel]

Kidney Dialysis Equipment is Estimated to Witness High Growth Owing to Increase in End Stage Renal Disease Patients

Kidney dialysis equipment are medical devices that filter and clean the blood of patients with renal failure. It helps remove waste and excess fluid from the blood when the kidneys are unable to perform these functions naturally. The major equipment include hemodialysis machines, dialyzer, dialysis solutions and catheters. Hemodialysis machines pump blood out of the body into a dialyzer that cleans it before returning it the circulation. It is commonly used to treat acute kidney injuries and patients awaiting kidney transplantation.

The global kidney dialysis equipment market is estimated to be valued at US$ 16,874.5 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The increase in end stage renal disease patients globally due to rise in diabetes, hypertension, and other chronic conditions is a major driver augmenting the growth of kidney dialysis equipment market. As per data by National Kidney Foundation, nearly 2 million patients with end stage renal disease require dialysis or kidney transplant globally. Hemodialysis is the most common type of treatment prescribed to such patients as it is considered safer, cheaper and widely available compared to other modalities. Additionally, technological advancements in dialysis equipment such as portable and home hemodialysis systems has made treatment more convenient to patients. However, risks of complications associated with dialysis including infections, hypotension and cardiovascular diseases may hamper the demand to certain extent. SWOT Analysis Strength: Kidney dialysis equipment provides life-saving treatment for patients with kidney failure. It helps filter waste and excess fluid from the blood when the kidneys are no longer able to perform this function effectively. The market is driven by the growing prevalence of chronic kidney diseases and end-stage renal diseases. Furthermore, technological advancements in dialysis machines have made treatment easier and more effective for patients. Weakness: Dialysis treatment is often life-long for patients with end-stage renal disease. It is also highly invasive, time-consuming, and resource-intensive. This raises the overall healthcare costs associated with treating kidney failure patients on dialysis. Additionally, quality of life often declines for patients requiring frequent and lengthy sessions. Opportunity: There is an opportunity to develop more portable and home-based dialysis systems. This would give patients greater flexibility and independence compared to center-based hemodialysis. Advancements in wearable and implantable artificial kidney technologies also present new opportunities. Growth in healthcare expenditure and improving access to insurance in developing economies also provides market opportunities. Threats: Strict regulatory approvals and reimbursement policies pose challenges to market players. Increasing cost pressures within healthcare systems also threaten profit margins. Rise of alternative treatment options like kidney transplants also takes away market share from dialysis over the long run. Key Takeaways The global kidney dialysis equipment market is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to increase from US$ 16,874.5 Mn in 2023 to US$ 28,918.9 Mn by 2030, expanding at a CAGR of 6.6%. Regional analysis: North America currently dominates the kidney dialysis equipment market, accounting for over 45% of the global market share in 2023. However, Asia Pacific is expected to witness the fastest growth during the forecast period. Factors such as the rising elderly population, growing prevalence of diabetes and hypertension, and improving access to healthcare in China and India will drive the kidney dialysis equipment market in the Asia Pacific region. Key players: Fresenius Medical Care AG & Co and Baxter International, Inc. have emerged as global leaders in the kidney dialysis equipment market. Other prominent players operating in the market are Nipro Corporation, B. Braun Melsungen AG, Nikkiso Co, Ltd., Asahi Kasei Corporation, NxStage Medical, Inc., Guangdong Biolight Meditech Co., Ltd, Dialife SA, and DaVita Inc. Key players are investing in innovative product launches and targeting high growth emerging markets through collaborations to consolidate their market position.

[kneepainsignsyourkneeinjur]

The Benefits of AV Fistula Surgery for Dialysis Patients

Introduction:

For individuals with kidney failure, dialysis becomes a lifeline, providing essential filtration for their blood. Among the different methods available, the creation of an arteriovenous (AV) fistula through surgery has emerged as the gold standard. In this blog, we will explore the numerous benefits that AV fistula surgery offers to dialysis patients, highlighting its advantages over alternative dialysis access options.

AV FISTULA Treatment in Pune by Dr. Hemant Chaudhari A vascular access lets large amounts of blood flow continuously during hemodialysis treatments to filter as much blood as possible per treatment.

Improved Long-Term Access:

AV fistula surgery involves connecting an artery and a vein, typically in the arm, to create a durable access point for dialysis. Compared to other options such as central venous catheters or synthetic grafts, AV fistulas have proven to be more reliable and long-lasting. The surgical procedure ensures that the connection becomes stronger over time, allowing for repeated dialysis sessions without the need for frequent interventions or replacements.

AV FISTULA Treatment in Pune by Dr. Hemant Chaudhari A vascular access lets large amounts of blood flow continuously during hemodialysis treatments to filter as much blood as possible per treatment.

Reduced Risk of Infection:

One of the significant advantages of AV fistula surgery is the decreased risk of infection. Unlike catheters or grafts that require external access points, an AV fistula is an internal connection, significantly minimizing the chances of contamination or infection. This is particularly crucial for dialysis patients who are already susceptible to infections due to compromised immune systems. By reducing the risk of infection, AV fistula surgery promotes better overall health outcomes.

Enhanced Dialysis Efficiency:

AV fistulas allow for better blood flow during dialysis treatments. The direct connection between an artery and a vein creates a natural pathway for blood to flow at an optimal rate, improving the efficiency of the dialysis process. This means that dialysis treatments can be performed more effectively, with better clearance of waste products and excess fluids from the body. Enhanced dialysis efficiency translates into improved overall well-being and a higher quality of life for patients.AV FISTULA Treatment in Pune by Dr. Hemant Chaudhari A vascular access lets large amounts of blood flow continuously during hemodialysis treatments to filter as much blood as possible per treatment.

Minimized Complications:

Compared to other dialysis access methods, AV fistulas are associated with fewer complications. Since they are created using the patient's own blood vessels, the risk of clotting, narrowing, or leakage is significantly reduced. This results in fewer instances of vascular access-related complications, ensuring a smoother dialysis experience for patients and minimizing the need for additional procedures or hospital visits.

Cost-Effectiveness:

From an economic perspective, AV fistula surgery offers substantial benefits for dialysis patients. While the initial surgical procedure incurs a cost, the long-term savings are significant. AV fistulas require minimal maintenance compared to catheters or grafts, which often necessitate ongoing monitoring, replacements, or repairs. By reducing the frequency of interventions and hospital visits, AV fistula surgery proves to be a cost-effective choice for both patients and healthcare systems.

Conclusion:

AV fistula surgery stands out as a highly beneficial option for dialysis patients. Its advantages, including improved long-term access, reduced risk of infection, enhanced dialysis efficiency, minimized complications, and cost-effectiveness, make it the preferred choice for many healthcare professionals and patients alike. If you are a dialysis patient or healthcare provider considering dialysis access options, consult with your healthcare team to determine if AV fistula surgery is the right choice for you or your patients.

[healthcare-market]

Portable Dialysis Devices Market to Garner Brimming Revenues by 2026

Global Portable Dialysis Devices Market: Introduction

A typical hemodialysis needs three sessions per week, for 3-5 hours per session, at a medical facility. Hemodialysis involves pumping a patient’s blood through an external circuit for filtration, before it is pumped back into the body. Hemodialysis is a common type of dialysis for about 90% of all dialysis patients. Peritoneal dialysis utilizes the patient’s own abdomen across which waste is exchanged from the blood and flushed out regularly through a permanent tube in the abdomen. Peritoneal dialysis does not require regular trips to a medical facility; however, it still requires regular treatment at home. Medicare coverage is extended to a person of any age who requires either dialysis or transplantation to maintain life. According to The Regents of the University of California, 750,000 people who live with end-stage renal disease (ESRD) are 1% of the U.S. Medicare population, but account for roughly 7% of the Medicare budget. Hemodialysis care costs the Medicare system an average of $90,000 per patient annually in the U.S., for a total of US$28 billion.

Read Report Overview: https://www.transparencymarketresearch.com/portable-dialysis-devices-market.html

Key Drivers of Global Portable Dialysis Devices Market

Increasing Number of ESRD Patients

According to National Institute of Diabetes and Digestive and Kidney Diseases, the overall prevalence of chronic kidney disease (CKD) in the general population is approximately 14%. Diabetes and high blood pressure are key causes of CKD. Half the population of individuals having CKD is also combined with cardiovascular disease (CVD) and diabetes. 661,000 people in the U.S. have kidney failure, 468,000 individuals are on dialysis, and 193,000 live with a functioning kidney transplant. Every year, renal disease kills more people than breast or prostate cancer. In 2013, more than 47,000 people in the U.S. died from kidney disease. Estimates are that 2 million people worldwide suffer from ESRD, and the number of patients diagnosed with the disease continues to increase at a rate of 5% to 7% per year. Taiwan, Japan, Mexico, the U.S., and Belgium currently have the highest prevalence of ESRD.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77622

Limited Availability of Donor Organs

Organ transplant is a cost-effective and life-saving option for patients with organ failure. According to American Medical Association, in the U.S., the supply of organs cannot meet the need of patients on the waiting list, resulting in prolonged morbidity and higher mortality for these patients. Approximately 7500 patients die yearly while awaiting an organ transplant. In the U.S., a suboptimal 54% of adults are registered organ donors, the lack follow up preventing a donation from 20% to 40% of eligible deceased donors.

Request For Discount - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77622

North America to Account for Major Share of Global Portable Dialysis Devices Market

· North America is projected to account for a major share of the global portable dialysis devices market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the next few years due to an increase in research & development and various government initiatives for the development of novel ideas. Europe is expected to be the second-largest market, globally, during the forecast period.

· The portable dialysis devices market in Asia Pacific is likely to expand at a high CAGR during the forecast period. This can be attributed to a rise in investment in research & development by private and government organizations and increase in healthcare management.

Pre-book Portable Dialysis Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=77622&ltype=S

Key Players Operating in Global Portable Dialysis Devices Market

The global portable dialysis devices market is highly consolidated, owing to the presence of a small number of key players.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/players-in-pressure-relief-devices-market-lean-on-launching-smart-therapeutic-beds-for-preventing-pressure-injuries-in-patients-market-valuation-to-reach-us-4-54-bn-by-2030--finds-tmr-301349292.html

https://www.prnewswire.com/news-releases/urgent-care-centers-market-valuation-to-reach-us-35-4-bn-by-2027-due-to-increased-access-to-healthcare-low-cost-of-treatment-finds-a-tmr-study-301355857.html

https://www.prnewswire.com/news-releases/rise-in-prevalence-of-dry-eye-disease-due-to-ageing-use-of-computers-to-drive-dry-eye-disease-treatment-market-says-tmr-301360562.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

[rohinic123-blog]

Portable Dialysis Devices Market Estimated to Record Highest CAGR by 2030

Global Portable Dialysis Devices Market: Introduction

A typical hemodialysis needs three sessions per week, for 3-5 hours per session, at a medical facility. Hemodialysis involves pumping a patient’s blood through an external circuit for filtration, before it is pumped back into the body. Hemodialysis is a common type of dialysis for about 90% of all dialysis patients. Peritoneal dialysis utilizes the patient’s own abdomen across which waste is exchanged from the blood and flushed out regularly through a permanent tube in the abdomen.

Report Overview @

https://www.transparencymarketresearch.com/portable-dialysis-devices-market.html

Peritoneal dialysis does not require regular trips to a medical facility; however, it still requires regular treatment at home. Medicare coverage is extended to a person of any age who requires either dialysis or transplantation to maintain life. According to The Regents of the University of California, 750,000 people who live with end-stage renal disease (ESRD) are 1% of the U.S. Medicare population, but account for roughly 7% of the Medicare budget. Hemodialysis care costs the Medicare system an average of $90,000 per patient annually in the U.S., for a total of US$28 billion.

Planning To Lay Down Future Strategy? Request Brochure Of Portable Dialysis Devices Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77622

Key Drivers of Global Portable Dialysis Devices MarketIncreasing Number of ESRD Patients

According to National Institute of Diabetes and Digestive and Kidney Diseases, the overall prevalence of chronic kidney disease (CKD) in the general population is approximately 14%. Diabetes and high blood pressure are key causes of CKD. Half the population of individuals having CKD is also combined with cardiovascular disease (CVD) and diabetes. 661,000 people in the U.S. have kidney failure, 468,000 individuals are on dialysis, and 193,000 live with a functioning kidney transplant. Every year, renal disease kills more people than breast or prostate cancer. In 2013, more than 47,000 people in the U.S. died from kidney disease. Estimates are that 2 million people worldwide suffer from ESRD, and the number of patients diagnosed with the disease continues to increase at a rate of 5% to 7% per year. Taiwan, Japan, Mexico, the U.S., and Belgium currently have the highest prevalence of ESRD.

Limited Availability of Donor Organs

Organ transplant is a cost-effective and life-saving option for patients with organ failure. According to American Medical Association, in the U.S., the supply of organs cannot meet the need of patients on the waiting list, resulting in prolonged morbidity and higher mortality for these patients. Approximately 7500 patients die yearly while awaiting an organ transplant. In the U.S., a suboptimal 54% of adults are registered organ donors, the lack follow up preventing a donation from 20% to 40% of eligible deceased donors.

To Obtain All-Inclusive Information On Forecast Analysis Of Portable Dialysis Devices Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=77622

North America to Account for Major Share of Global Portable Dialysis Devices Market

North America is projected to account for a major share of the global portable dialysis devices market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the next few years due to an increase in research & development and various government initiatives for the development of novel ideas. Europe is expected to be the second-largest market, globally, during the forecast period.

The portable dialysis devices market in Asia Pacific is likely to expand at a high CAGR during the forecast period. This can be attributed to a rise in investment in research & development by private and government organizations and increase in healthcare management.

Request For Covid19 Impact Analysis –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77622

Key Players Operating in Global Portable Dialysis Devices Market

The global portable dialysis devices market is highly consolidated, owing to the presence of a small number of key players. Leading players operating in the global portable dialysis devices market include:

B. Braun Melsungen AG

Baxter International Inc

AllMed Healthcare Management, Inc

Asahi Kasei Corporation

Fresenius Kabi AG

AWAK Technologies

Quanta Dialysis Technologies Ltd

Medtronic

Nipro

More Trending Reports by Transparency Market Research –

Burn Injury Treatment Market -

https://www.prnewswire.com/news-releases/tmr-projects-robust-growth-for-burn-injury-treatment-market-rising-effective-treatment-options-to-drive-5-0-cagr-during-2019-2027--301015170.html

Thrombectomy Devices Market –

https://www.biospace.com/article/thrombectomy-devices-market-growing-preference-for-minimally-invasive-surgeries-to-fuel-demand-for-thrombectomy-devices/

[phgq]

ARQCapital boosts bid to set up more dialysis centers in PH

#PHnews: ARQCapital boosts bid to set up more dialysis centers in PH

MANILA -- Pioneering dialysis chain operator MedLine has secured funding from ARQCapital for the establishment of stand-alone dialysis centers in key areas in the country, giving Filipinos better access to affordable dialysis treatment.

Kidney-related diseases are consistently among the top 10 most common causes of death in South East Asia.

Chronic kidney disease regresses toward end-stage renal disease (ESRD) which can be described by the necessity to perform life-saving dialysis or kidney transplantation, although the issue with the latter is that there is a shortage of donors.

Worldwide, the number of patients receiving renal replacement therapy (RRT) was estimated at more than 1.4 million cases with incidence growing at approximately 8 percent annually.

In the Philippines, this number is even greater. As of 2018, it is estimated that the number of cases of kidney diseases are increasing at a rate of 10 percent to 15 percent each year.

However, it is also estimated that only two out of three patients diagnosed with ESRD are going through dialysis.

This leaves a huge portion of patients with this illness in desperate need of proper treatment for their condition.

There are several reasons as to why it can be difficult for patients with ESRD to receive treatment.

One of the biggest issues is the cost related to medical expenses.

The average cost of a hemodialysis session in the Philippines is about PHP4,500.

Given that the recommended frequency of sessions per week is three times, then the total amount of expenses for a dialysis patient is PHP13,500 per week – a large expense for the average Filipino.

Going through dialysis thrice a week roughly equates to 156 sessions per year per patient.

Of this number, PhilHealth sponsors 90 sessions, while certain government agencies, like the Department of Social Welfare and Development (DSWD) and the Philippine Charity Sweepstakes Office (PCSO), help in subsidizing treatment costs. Most patients incur out of pocket expenses, hence the need for low-cost hemodialysis facilities.

Another reason why a large number of ESRD patients are unable to receive medical care is the shortage of dialysis centers throughout the country.

People with this disease that live in remote locations often have great difficulty accessing low-cost dialysis centers where they can get proper treatment.

As a result, their health conditions inevitably become worse, therefore more accessible and affordable dialysis centers need to be established throughout the country.

This is exactly why MedLine Dialysis Center Franchising has been aggressively building corporate branches and promoting their franchising opportunity.

Brothers Alexander and Sonny Lim established MedLine in 2015, with the goal of becoming the leader in the fast-growing but highly fragmented USD300-million Philippine hemodialysis market.

To grow faster and make affordable dialysis available across the country, the group partnered with Francorp to design the first dialysis franchise program in the Philippines.

Since 2018, the brand has been adding an average of one to two new franchises every month and is planning to add 20 franchises over the coming 12 months, in locations such as Baguio, Cavite, Laguna, Batangas, Cebu, Davao and Cagayan de Oro.

ARQCapital, meanwhile, was established in 2014 and has since become a leading boutique investment firm focused on providing growth capital to promising entrepreneurs and small and medium enterprises (SMEs) in the Philippines in key sectors such as food and agriculture, consumer, social infrastructure, and financial services. (PR)

   ***

References:

* Philippine News Agency. "ARQCapital boosts bid to set up more dialysis centers in PH." Philippine News Agency. https://www.pna.gov.ph/articles/1086669 (accessed November 22, 2019 at 04:22AM UTC+14).

* Philippine News Agency. "ARQCapital boosts bid to set up more dialysis centers in PH." Archive Today. https://archive.ph/?run=1&url=https://www.pna.gov.ph/articles/1086669 (archived).

[nefronkidneycare]

Are you looking for the best renal biopsy centre in Siliguri. Then Nefron provides best renal biopsy treatment with affordable price. Contact now.

[we-arnold-lockshin-blog]

U.S. medical insurers "charge as much as they can"

Факты, которые  подконтрольные ЦРУ СМ»И»  в России скрывают...

Dictatorship USA – Run By A Plundering and Murderous Ruling Class  — 2019 (606)

First kidney failure, then a $540,842 bill for dialysis

The bill was more than the typical cost of a kidney transplant.

NBC News, July 25, 2019

For months, Sovereign Valentine had been feeling progressively run-down. The 50-year-old personal trainer, who goes by “Sov,” tried changing his workout and diet to no avail.

Finally, one Sunday, he drove himself to the hospital in the small town of Plains, Mont., where his wife, Jessica, happened to be the physician on call. “I couldn’t stop throwing up. I was just toxic.”

It turned out he was in kidney failure and needed dialysis immediately.  “I was in shock, but I was so weak that I couldn’t even worry,” he said.

He was admitted to a nearby hospital that was equipped to stabilize his condition and to get his first dialysis session. A social worker there arranged for him to follow up with outpatient dialysis, three times a week. She told them Sov had two options, both about 70 miles from his home. They chose a Fresenius Kidney Care clinic in Missoula.

A few days after the treatments began, an insurance case manager called the Valentines warning them that since Fresenius was out-of-network, they could be required to pay whatever the insurer didn’t cover.

Jessica repeatedly asked both the dialysis clinic staff and the insurer how much they could expect to be charged, but couldn’t get an answer.

Then the bills came:

Patient: Sovereign Valentine, 50, a personal trainer in Plains, Mont. He is insured by Allegiance, through his wife’s work as a doctor in a rural hospital.

Total Bill: $540,841.90 for 14 weeks of dialysis care at an out-of-network Fresenius clinic. Valentine’s insurer paid $16,241.72. The clinic billed Valentine for the unpaid balance of $524,600.17.

Service Provider: Fresenius Medical Care, one of two companies (along with rival DaVita) that control about 70 percent of the U.S. dialysis market.

Medical Treatment: Hemodialysis at an outpatient Fresenius clinic, three days a week for 14 weeks.

What Gives: As the dominant providers of dialysis care in the U.S., Fresenius and DaVita together form what health economists call a “duopoly.” They can demand extraordinary prices for the lifesaving treatment they dispense — especially when they are not in a patient’s network. A 1973 law allows all patients with end-stage renal disease like Sov to join Medicare, even if they’re younger than 65 — but only after a 90-day waiting period. During that time, patients are extremely vulnerable, medically and financially.

Fresenius billed the Valentines $524,600.17 — an amount that is more than the typical cost of a kidney transplant. It’s also nearly twice Jessica’s medical school debt. Fresenius charged the Valentines $13,867.74 per dialysis session, or about 59 times the $235 Medicare pays for a dialysis session.

Dialysis companies are quite profitable. Fresenius reported more than $2 billion in profits in 2018, with the vast majority of its revenue coming from North America. The discrepancy in payments between Medicare and commercial payers gives dialysis centers an incentive to treat as many privately insured patients as possible and to charge as much as they can.

//////////////////////////////////////

Перед нами - коварный и опасный мошенник, расист, лжец и фашист Дональд Трамп, порочный Конгресс, нацистские ФБР - ЦРУ, кровавые милитаристы США и НАТО >>> а также и лживые, вредоносные американские СМ»И».

Нынешние киевские власти — фашистские агенты американского империализма...  Именно то, чего хотят Трамр/ США и в Венесуэле!

А также в Иране. А также в Cирии.  Затем и в России!

/////////////////////////////////////////////

Правительство США жестоко нарушало мои права человека при проведении кампании террора, которая заставила меня покинуть свою родину и получить политическое убежище в СССР. См. книгу «Безмолвный террор — История политических гонений на семью в США» - "Silent Terror: One family's history of political persecution in the United States» - http://arnoldlockshin.wordpress.com

Правительство США еще нарушает мои права, за 15 лет отказывается от выплаты причитающейся мне пенсии по старости.  Властители США воруют пенсию!!  

ФСБ - Федеральная служба «безопасности» России - вслед за позорным, предавшим страну предшественником КГБ, мерзко выполняет приказы секретного, кровавого хозяина (boss) - американского ЦРУ (CIA). Среди таких «задач» -  мне запретить выступать в СМИ и не пропускать отправленных мне комментариев.   А это далеко, далеко не всё...

Арнольд Локшин, политэмигрант из США

BANNED – ЗАПРЕЩЕНО!!

ЦРУ - ФСБ забанили все мои посты, комментарии в Вконтакте, в Макспарке, в Facebook (“a dangerous account — your post goes against our Community Standards so only you can see it”), в Twitter (“Your account is suspended and is not permitted to perform this action”), в Medium.com... и удаляют ещё много других моих постов!

[parthabanerjeeofficial-blog]

[Partha Banerjee Dubai] : Poor Maintenance of Dialysis in Africa

Lack of funding for maintenance dialysis is arguably the single most important barrier to the provision of maintenance dialysis in sub-Saharan Africa. In most parts of the region, there are no reimbursements or government subsidies for dialysis and national health insurance programs do not exist. According to Partha Banerjee Dubai, this has led to a situation where patients have to pay out-of-pocket for dialysis. On a continent where up to 80% the population live on less than 2.5 dollars per day and a session of hemodialysis costs as much as USD 100 – 200 most patients with ESRD have to rely on financial support from their extended families, religious organizations and philanthropists to be able to pay for dialysis says partha banerjee dubai . Even where government subsidies or payments are available to cover dialysis, many patients with ESRD are denied access to long-term dialysis because of rationing policies that limit the provision of dialysis to the patient with few co-morbidities.

[pragya1-blog]

Nocturnal Dialysis Market  : Growth, Trends and Demands Research Report and Forecast  2026

End-stage renal disease (ESRD) is a major health issue affecting millions of people around the world. The incidence of chronic kidney diseases (CKD) is increasing at a higher rate in emerging countries owing to sedentary lifestyles, increasing incidence of diabetes among the general population, and higher prevalence of hypertension. Renal replacement therapy (RRT) for treatment of end-stage renal diseases (ESRD) involves high costs and burdens the health care resources of a country. Hemodialysis and peritoneal dialysis have emerged as one of the most prominent treatment options for people suffering from end-stage renal disease (ESRD). However, recent studies regarding patient outcomes for hemodialysis have led health care providers toward new therapies and regimes such as nocturnal dialysis. This procedure is performed at night and is usually performed for longer duration such as 8 to 10 hours compared to conventional hemodialysis.

Obtain Report Details @

https://www.transparencymarketresearch.com/nocturnal-dialysis-market.html

Increasing incidence of chronic kidney diseases (CKD) and rising incidence of diabetes are leading to a large patient population suffering from end-stage renal disease (ESRD) requiring dialysis. Various clinical studies conducted by health care agencies have indicated that patients undergoing conventional hemodialysis have a high mortality rate and a low quality of life (increasing dependence on dialysis, loss of employment, etc.). Conventional hemodialysis also involves higher cost of care. These factors have been eliminated by nocturnal dialysis as the procedure is performed overnight for more than eight hours as compared to conventional hemodialysis sessions lasting for two to three hours. Nocturnal dialysis leads to improved efficiency of the dialysis procedure, reduced dialysis cycles per patient, and improved quality of life for patients. These factors, combined with increasing number of manufacturers and health care providers offering nocturnal dialysis, are expected to drive the expansion of the global nocturnal dialysis market during the forecast period. However, lack of awareness among the general population and low quality of care provided in emerging countries are leading to lower adoption of nocturnal dialysis in these countries. This is restraining the expansion of the global market.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43646

The global nocturnal dialysis market can be segmented based on product, end- user, and region. In terms of product, the global nocturnal dialysis market can be categorized into dialysis machines (clinical units and home use dialysis machines) and consumables (AV grafts, catheters, dialyzers, blood lines, and transfer sets, etc.). The dialysis machines segment accounted for a prominent share of the market in terms of value in 2017. The consumables segment is expected to expand at a comparatively higher CAGR during 2018-2026, owing to the disposable nature of consumables and increasing number of patients undergoing nocturnal dialysis. Based on end-user, the global nocturnal dialysis market can be classified into hospitals, dialysis centers, home care settings, and other end-users. The hospitals segment is expected to expand at a comparatively higher CAGR during the forecast period, owing to large patient pool preferring hospitals for nocturnal dialysis due to adequate reimbursement policies.

Enquiry for Discount on this Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=43646

In terms of region, the global nocturnal dialysis market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global nocturnal dialysis market in 2017. Higher prevalence of end-stage renal disease (ESRD) and other chronic diseases such as diabetes in the U.S. and increasing awareness among the general population about availability of nocturnal dialysis are presenting a large patient pool undergoing nocturnal dialysis in the country. Also, presence of large manufacturers in the U.S. offering new and advanced products in the market is expected to lead to increasing demand and consumption of nocturnal dialysis products in North America during 2018-2026. The market in Asia Pacific is expected to expand at a significant CAGR during 2018-2026.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research State Tower, 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: www.transparencymarketresearch.com

[nefronkidneycare]

Are you looking for the best hemodialysis center in Siliguri. Then Nefron is a best choise for you. Contact now.

[nefronkidneycare]

Renal transplantation is a medical procedure in which a healthy kidney from a donor is transplanted into a patient with kidney disease.

The healthy kidney replaces the diseased one and helps to filter waste from the body, regulate electrolyte balance, and produce hormones that are necessary for the proper functioning of the body.

[nefronkidneycare]

A dialysis catheter is a medical device used to provide access to the vascular system for hemodialysis, a procedure used to filter toxins from the blood of people with kidney failure. Dialysis catheter insertion is a procedure performed to provide access to the vascular system for hemodialysis. The procedure is usually performed by an interventional radiologist or vascular surgeon and is done under sterile conditions.

[nefronkidneycare]

Hemodialysis is a medical procedure used to filter a patient's blood when their kidneys are not functioning properly. It is a life-saving procedure for those with end-stage kidney disease and is used to remove waste products and excess fluid from the body.

[nefronkidneycare]

Nefron is a Complete Kidney Care center with the aim of serving the society for the best.